Terms: = Brain cancer AND uPA AND Prognosis
12 results:
1. A role for caveola-forming proteins caveolin-1 and CAVIN1 in the pro-invasive response of glioblastoma to osmotic and hydrostatic pressure.
Pu W; Qiu J; Nassar ZD; Shaw PN; McMahon KA; Ferguson C; Parton RG; Riggins GJ; Harris JM; Parat MO
J Cell Mol Med; 2020 Mar; 24(6):3724-3738. PubMed ID: 32065471
[TBL] [Abstract] [Full Text] [Related]
2. Matrix protease production, epithelial-to-mesenchymal transition marker expression and invasion of glioblastoma cells in response to osmotic or hydrostatic pressure.
Pu W; Qiu J; Riggins GJ; Parat MO
Sci Rep; 2020 Feb; 10(1):2634. PubMed ID: 32060379
[TBL] [Abstract] [Full Text] [Related]
3. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
[TBL] [Abstract] [Full Text] [Related]
4. Correlation of the invasive potential of glioblastoma and expression of caveola-forming proteins caveolin-1 and CAVIN1.
Pu W; Nassar ZD; Khabbazi S; Xie N; McMahon KA; Parton RG; Riggins GJ; Harris JM; Parat MO
J Neurooncol; 2019 Jun; 143(2):207-220. PubMed ID: 30949900
[TBL] [Abstract] [Full Text] [Related]
5. Expression of Tax-interacting protein 1 (TIP-1) facilitates angiogenesis and tumor formation of human glioblastoma cells in nude mice.
Han M; Wang H; Zhang HT; Han Z
Cancer Lett; 2013 Jan; 328(1):55-64. PubMed ID: 23010083
[TBL] [Abstract] [Full Text] [Related]
6. upa/PAI-1 expression and upa promoter methylation in meningiomas.
Kandenwein JA; Park-Simon TW; Schramm J; Simon M
J Neurooncol; 2011 Jul; 103(3):533-9. PubMed ID: 20862517
[TBL] [Abstract] [Full Text] [Related]
7. Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61.
Young N; Pearl DK; Van Brocklyn JR
Mol Cancer Res; 2009 Jan; 7(1):23-32. PubMed ID: 19147534
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme.
Hall WA; Vallera DA
Neurosurg Focus; 2006 Apr; 20(4):E23. PubMed ID: 16709029
[TBL] [Abstract] [Full Text] [Related]
9. [Tumor-associated prognostic factors of the plasminogen activator family: determination and clinical value of u-PA, t-PA, PAI-1, and PAI-2].
Mengele K; Harbeck N; Reuning U; Magdolen V; Schmitt M
Hamostaseologie; 2005 Aug; 25(3):301-10. PubMed ID: 16113755
[TBL] [Abstract] [Full Text] [Related]
10. [Expression and significance of urokinase-type plasminogen activator in medulloblastoma].
Wang Y; Mao B; Zhang S; Cheng H
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):376-8. PubMed ID: 12536568
[TBL] [Abstract] [Full Text] [Related]
11. Targeting urokinase-type plasminogen activator receptor on human glioblastoma tumors with diphtheria toxin fusion protein DTAT.
Vallera DA; Li C; Jin N; Panoskaltsis-Mortari A; Hall WA
J Natl Cancer Inst; 2002 Apr; 94(8):597-606. PubMed ID: 11959893
[TBL] [Abstract] [Full Text] [Related]
12. The fibrinolytic system in neoplasia.
Bell WR
Semin Thromb Hemost; 1996; 22(6):459-78. PubMed ID: 9122711
[TBL] [Abstract] [Full Text] [Related]
